T

Tsreenivasan

Active Director Director DIN 08253878
DIN 08253878 First appointment Sep 2018 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2018
Shareholding value •••• Premium profile

About Tsreenivasan

Data last updated:

Tsreenivasan is a Director at Arable Biotech Private Limited (since 2018). The company operates in Chemicals. Arable Biotech Private Limited reported revenue of ₹88,439 (FY 2025).

DIN 08253878
Primary Designation Director
Industry Chemicals
First Appointment 29 Sep 2018
Oldest Company Age 10 yrs
Largest company Arable Biotech Private Limited · ₹88,439 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arable Biotech Private Limited U01100DL2016PTC298998
Director29 Sep 20182016₹88,439 (FY 2025)Active

Board colleagues of Tsreenivasan

NameDINCompanyDesignation
Sudha Sreenivasan07466613Arable Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Arable Biotech Private Limited
Premium access

Shareholding and investment profile for Tsreenivasan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tsreenivasan

Tsreenivasan currently holds 1 directorship: Arable Biotech Private Limited (Director, since 29 Sep 2018, revenue ₹88,439 (FY 2025)).

Tsreenivasan was first appointed on 29 Sep 2018 as Director at Arable Biotech Private Limited.

The current boards of Tsreenivasan's companies include Sudha Sreenivasan (Arable Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available